Candidiasis

Fungal infections caused by opportunistic pathogens are increasingly observed in both community and healthcare settings, particularly among individuals with weakened immune systems. Candidiasis is a common fungal infection caused by Candida species, affecting mucosal surfaces, skin, and in severe cases, leading to invasive systemic disease. Its clinical significance has grown due to rising antifungal resistance and increased use of immunosuppressive therapies. This session at the Infectious Diseases Conference focuses on the epidemiology, diagnosis, and management of candidiasis across diverse patient populations.

Candidiasis presents in multiple forms, ranging from superficial infections such as oral thrush and vaginal candidiasis to life-threatening invasive infections affecting the bloodstream and internal organs. Risk factors include prolonged hospitalization, use of broad-spectrum antibiotics, medical device implantation, and underlying chronic illnesses. Early identification and appropriate antifungal therapy are essential to prevent complications. Advances in diagnostic tools, including molecular assays and biomarker detection, have improved the accuracy and speed of diagnosis.

An equivalent term, Candida Infections, reflects the same condition and is widely used in clinical and research contexts. Effective management requires a combination of timely diagnosis, targeted antifungal treatment, and infection control practices. Preventive strategies such as minimizing unnecessary antibiotic use and maintaining proper hygiene are also critical in reducing incidence rates.

Emphasizing clinical best practices and emerging research, this session delivers valuable insights into improving patient care, enhancing diagnostic capabilities, and addressing challenges associated with candidiasis in modern healthcare systems.